Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GreenLight Biosciences is a pre-commercial biotechnology company developing RNA-based products for agriculture and human health. Its proprietary cell-free RNA platform enables rapid, affordable production of RNA-based solutions for crop protection, vaccine development, and medical therapeutics. Most products are in late-stage field trials (agriculture) or preclinical/early clinical development (human health). The company was acquired in 2023 by a consortium led by Fall Line Capital after a period as a public company[1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Green Light Group.